Insider Purchases at Gamestop and the Nathan's Famous Acquisition – The Special Situations Report Episode #51

Episode Summary

Executive Summary: Episode 51 covers several event-driven situations: skepticism around rumored deals like ABVAX and Mission Produce, the announced Smithfield Foods acquisition of Nathan’s Famous with potential CFIUS scrutiny, and notable insider buying at Under Armour and GameStop. The hosts emphasize that rumors often fail, but insider buying and capital allocation can reveal deeper strategic shifts, especially at GameStop.

Main Topics: Rumored deals are often unreliable (Priority: 5/5): The hosts revisit the ABVAX-Eli Lilly rumor and note that ABVAX’s CEO and the French government denied takeover talks, reinforcing that many rumored deals never become real transactions. Mission Produce and Calavo deal faces friction (Priority: 4/5): Global Harvest Holdings increased its stake in Calavo Growers, prompting Mission Produce to adopt a one-year poison pill to defend against potential interference and address possible antitrust/regulatory concerns. Smithfield Foods acquires Nathan’s Famous (Priority: 5/5): Smithfield agreed to buy Nathan’s Famous in an all-cash $450 million deal at $102 per share, a modest premium, with the hosts highlighting brand value, licensing logic, and the likelihood of CFIUS review due to WH Group ownership. Under Armour insider buying by Prem Watsa (Priority: 4/5): Prem Watsa continued buying Under Armour, including both Class A and non-voting Class C shares, signaling that he appears focused on economic exposure rather than governance control. GameStop insider buying and strategic optionality (Priority: 5/5): Ryan Cohen and a director bought shares while the hosts dissected GameStop’s balance sheet, large cash pile, interest income, debt structure, and possible strategic pivots beyond the legacy retail business. Capital allocation and transformation as the real story (Priority: 4/5): The episode frames GameStop as a company that has turned meme-stock dilution and cheap debt into cash, and now faces the challenge of deploying capital into acquisitions or other initiatives that can create durable value.

Key Arguments: Rumored deal activity should be treated cautiously because only about 42-43% of rumored deals end in an actual transaction; the majority do not. International rumor-driven deals are harder to complete in the current environment, making ABVAX a cautionary example. Mission Produce’s poison pill suggests the Calavo transaction may face activism or resistance, especially given regulatory concerns in a two-avocado-producer merger. Smithfield’s purchase of Nathan’s Famous is strategically about securing perpetual rights to a well-known brand rather than only near-term financial returns. Despite only a small spread, the Nathan’s deal could still face political and CFIUS scrutiny because Smithfield is tied to China through its largest shareholder. Prem Watsa’s buying of Under Armour Class C shares indicates he values economic ownership over voting control. GameStop’s earnings improvement is driven largely by interest income on its huge cash position, not by core retail growth. GameStop’s future likely depends on disciplined capital deployment, potentially through acquisitions, rather than simply becoming a Bitcoin treasury company. Ryan Cohen’s long-term performance award aligns his compensation with aggressive market-cap and EBITDA hurdles, suggesting a transformative strategy rather than incremental turnaround. The company’s meme-stock history gave it a large cash reserve, but the next challenge is generating operating profits from that capital.

Data Points: ABVAX rumored-deal completion rate: 42-43% - Hosts cite their data on rumored deals ending in an actual transaction ABVAX capital runway: Through end of 2027 - Used to argue the company is not under immediate pressure to sell Global Harvest Holdings stake in Calavo Growers: 12.52% - After acquiring an additional 8.8 million shares Initial Global Harvest stake in Calavo: 6.27% - First reported purchase in mid-2025 Poison pill ownership threshold: 15% - Mission Produce can redeem rights before any holder reaches this level Smithfield acquisition value for Nathan’s Famous: $450 million - All-cash merger agreement Nathan’s Famous offer price: $102 per share - Cash consideration in the Smithfield deal Nathan’s premium to prior close: About 10% - Hosts describe the valuation premium Nathan’s stock price before sale rumors: Around $87 - Referenced as the level when FT reported sale talks in February 2025 Smithfield license expiration: March 2032 - Existing Nathan’s manufacturing/sales rights were scheduled to expire then CIFIUS review: Required - Because Smithfield is tied to Hong Kong-based WH Group Prem Watsa Under Armour buying: More than half of total insider buying last week - His purchases dominated weekly insider buying activity Under Armour share types bought: Class A and Class C - Class C shares have no voting rights Under Armour stock move after Watsa purchase coverage: Up more than 22% - Price performance since earlier coverage Ryan Cohen GameStop purchase: Almost $23 million - Insider buying last week Alain Attal GameStop purchase: Close to $500,000 - Smaller insider purchase alongside Cohen's Ryan Cohen estimated net worth: About $5 billion - Used to contextualize his GameStop purchase size GameStop cash position: Nearly $8 billion - Balance sheet cash generating significant interest income GameStop marketable securities: $1 billion - Additional liquid investments on the balance sheet GameStop Bitcoin holdings: More than $519 million - Digital assets included separately from cash and securities GameStop long-term debt: Over $4 billion - Primarily 0% convertible notes GameStop stock price reference: Around $110,000 to $87,000 per Bitcoin - Hosts note Bitcoin’s decline and its effect on crypto treasury company valuations Ryan Cohen performance award shares: 171.54 million shares - Total potential long-term award if hurdles are achieved Potential ownership from award: Almost 29% of diluted shares outstanding - At current share count if fully earned First award hurdle: $20 billion market cap and $2 billion cumulative EBITDA - First 10% tranche of the award Top award hurdle: $100 billion market cap and $10 billion cumulative EBITDA - Final tranche in the award structure

Pivotal Quotes: "rumored deals in the works are rumors at the end of the day and may not always come to fruition" — Asif Surya: General caution about deal rumors after discussing ABVAX "we are not to be distracted" — ABVAX CEO (paraphrased in transcript): CEO response dismissing Eli Lilly acquisition speculation "he's more interested in the economic interest that Under Armour provides rather than the voting options" — Tamana Surya: Analysis of Prem Watsa buying both voting and non-voting shares

Implications: Listeners should treat deal rumors cautiously, watch for regulatory/political risk in cross-border M&A, and pay close attention to insider buying as a signal of conviction. GameStop’s story now hinges on capital allocation and execution, not meme-stock momentum.